Zur Rose Group – Marke
Corporate Governance
Downloads - Annual Report 2018 | Zur Rose Group AG
FY 2021 IFRS RESULTS - EuroChem Group
Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity
Olaf Heinrich, Head Germany, verlässt die Zur Rose-Gruppe; sein Nachfolger wird Walter Hess, Head Switzerland
Zur Rose - News und Aktienkurs | Finanz und Wirtschaft
Zur Rose Group (SWX:ROSE) - Share price, News & Analysis - Simply Wall St
Zur Rose Aerzte AG Share Price CHF5.75
ZUR ROSE GROUP AG : Shareholders Board Members Managers and Company Profile | CH0042615283 | MarketScreener
Zur Rose Group - Pharmaceuticals - Overview, Competitors, and Employees | Apollo.io
Zur Rose Group Company Profile: Stock Performance & Earnings | PitchBook
Zur Rose Group AG
Acquisitions by Zur Rose Group | Tracxn
IR Release FY 2011 - Schaeffler Group
Financials - Annual Report 2020 | Zur Rose Group AG
Christoph Herrmann - Director Investor Relations - Zur Rose Group AG | XING
Zur Rose Group AG
Christoph Herrmann – Head of Investor Relations – Zur Rose Group | LinkedIn
Zur Rose Group AG - Crunchbase Company Profile & Funding
Olaf Heinrich, Head Germany, is leaving the Zur Rose Group; his successor will be Walter Hess, Head Switzerland
The NAGA Group AG: Products, Stock, News
ACXIT Capital Partners advises medpex on the trade sale of its e-commerce activities to Zur Rose Group - ACXIT Capital Partners
Our 2020 in review | UBS Global
